BioSpecifics Technologies Corporation Reports Fourth Quarter And Full Year 2013 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LYNBROOK, N.Y., March 6, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2013 and provided a corporate update.

Help employers find you! Check out all the jobs and post your resume.

Back to news